Published in Osteoarthritis Cartilage on November 01, 2004
RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. Arthritis Res Ther (2012) 1.59
Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther (2010) 1.52
Premorbid knee osteoarthritis is not characterised by diffuse thinness: the Framingham Osteoarthritis Study. Ann Rheum Dis (2008) 1.27
Quantitative imaging of cartilage and bone morphology, reactive oxygen species, and vascularization in a rodent model of osteoarthritis. Arthritis Rheum (2012) 0.96
Quantitative cartilage imaging in knee osteoarthritis. Arthritis (2010) 0.94
Cartilage thickening in early radiographic knee osteoarthritis: a within-person, between-knee comparison. Arthritis Care Res (Hoboken) (2012) 0.88
Region of interest analysis: by selecting regions with denuded areas can we detect greater amounts of change? Osteoarthritis Cartilage (2009) 0.87
Effects of increased chronic loading on articular cartilage material properties in the lapine tibio-femoral joint. J Biomech (2010) 0.87
Cartilage thickness in the hip measured by MRI and stereology before and after periacetabular osteotomy. Clin Orthop Relat Res (2010) 0.86
The effects of bone turnover rate on subchondral trabecular bone structure and cartilage damage in the osteoarthritis rat model. Rheumatol Int (2009) 0.85
Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy. Eur J Nucl Med Mol Imaging (2007) 0.85
Changes induced by chronic in vivo load alteration in the tibiofemoral joint of mature rabbits. J Orthop Res (2012) 0.82
Use magnetic resonance imaging to assess articular cartilage. Ther Adv Musculoskelet Dis (2012) 0.81
Ultrasonographic measurement of the femoral cartilage thickness in patients with occupational lead exposure. J Expo Sci Environ Epidemiol (2014) 0.79
Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis. BMC Vet Res (2014) 0.78
Effect of Matching or Overconstraining Knee Laxity During Anterior Cruciate Ligament Reconstruction on Knee Osteoarthritis and Clinical Outcomes: A Randomized Controlled Trial With 84-Month Follow-up. Am J Sports Med (2016) 0.77
Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol (2016) 0.77
Altered swelling and ion fluxes in articular cartilage as a biomarker in osteoarthritis and joint immobilization: a computational analysis. J R Soc Interface (2015) 0.76
Evaluation of the disco-vertebral junction using ultrashort time-to-echo magnetic resonance imaging: inter-reader agreement and association with vertebral endplate lesions. Skeletal Radiol (2016) 0.76
Imaging longitudinal changes in articular cartilage and bone following doxycycline treatment in a rabbit anterior cruciate ligament transection model of osteoarthritis. Magn Reson Imaging (2011) 0.76
[Imaging of osteoarthritis of the peripheral joints]. Z Rheumatol (2007) 0.75
Effects of diacerein on cartilage and subchondral bone in early stages of osteoarthritis in a rabbit model. BMC Vet Res (2015) 0.75
Comparison of T1rho and T2 Mapping of Knee Articular Cartilage in an Asymptomatic Population. Korean J Radiol (2016) 0.75
Inhomogeneous Response of Articular Cartilage: A Three-Dimensional Multiphasic Heterogeneous Study. PLoS One (2016) 0.75
Osteoarthritis in the Knee Joints of Göttingen Minipigs after Resection of the Anterior Cruciate Ligament? Missing Correlation of MRI, Gene and Protein Expression with Histological Scoring. PLoS One (2016) 0.75
Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits. BMC Musculoskelet Disord (2015) 0.75
Does cartilage volume measurement or radiographic osteoarthritis at baseline independently predict ten-year cartilage volume loss? BMC Musculoskelet Disord (2016) 0.75
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2003) 7.95
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2004) 4.94
Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol (2001) 4.50
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 2.75
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.66
Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol (1992) 2.30
Fungal flora of the normal human small and large intestine. N Engl J Med (1969) 2.25
A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis (2011) 2.24
Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res (2000) 2.12
Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int (2001) 2.10
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis (2009) 1.95
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia (2011) 1.94
Angiotensin II and renal fibrosis. Hypertension (2001) 1.87
Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation (1991) 1.85
Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest (1994) 1.84
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage (2003) 1.79
IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol (1980) 1.75
Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension (2001) 1.72
Dilated cardiomyopathies of the adult (first of two parts). N Engl J Med (1982) 1.65
Nuclear retention of RNA as a mechanism for localization. RNA (1995) 1.57
Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol (1990) 1.55
Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation (1986) 1.55
Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation (2000) 1.51
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int (2001) 1.50
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol (1998) 1.45
Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients. Kidney Int (2006) 1.45
Health seeking behaviour for child illness in rural Guatemala. Trop Med Int Health (1996) 1.44
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol (2001) 1.42
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol (1998) 1.41
Insulin-like growth factor I - a novel biomarker of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2011) 1.40
"Borderline" myocarditis: an indication for repeat endomyocardial biopsy. J Am Coll Cardiol (1990) 1.39
Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells. Curr Biol (1999) 1.39
Familial IgA nephropathy associated with bilateral sensorineural deafness. Am J Kidney Dis (1992) 1.39
Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. Immunopharmacology (1982) 1.39
Mutational analysis identifies functional domains in the influenza A virus PB2 polymerase subunit. J Virol (1996) 1.38
Percutaneous balloon valvotomy for patients with severe mitral stenosis. Circulation (1987) 1.37
Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease. Clin Exp Immunol (1982) 1.35
Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes. Clin Exp Immunol (1983) 1.34
Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int (2006) 1.34
Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis (1999) 1.34
T-cell dysfunctions in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis. Clin Immunol Immunopathol (1983) 1.32
3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res (1998) 1.31
Proximal jet size by Doppler color flow mapping predicts severity of mitral regurgitation. Clinical studies. Circulation (1995) 1.30
Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens (2001) 1.30
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Ann Rheum Dis (2004) 1.28
A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schönlein-Henoch syndrome. Proc Eur Dial Transplant Assoc (1980) 1.26
HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS (2001) 1.25
Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay. J Hum Virol (2002) 1.25
Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol (1994) 1.23
Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits. Osteoarthritis Cartilage (2006) 1.19
Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int (2000) 1.17
Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart (2006) 1.16
Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin Exp Immunol (1982) 1.15
Antibodies to Bartonella bacilliformis as determined by fluorescence antibody test, indirect haemagglutination and ELISA. Trop Med Parasitol (1985) 1.13
Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. Am J Physiol Heart Circ Physiol (2009) 1.13
Immunological abnormalities in the tonsils of patients with IgA nephropathy: inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis. Clin Exp Immunol (1984) 1.13
Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage (2011) 1.13
Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol (2000) 1.12
Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int (2001) 1.12
Potential role of nuclear factor κB in diabetic cardiomyopathy. Mediators Inflamm (2011) 1.12
The epidemiology of clinically apparent HIV infection in Nicaragua. Eur J Clin Microbiol Infect Dis (2007) 1.12
Bone mineral measurements of subchondral and trabecular bone in healthy and osteoporotic rabbits. Skeletal Radiol (2005) 1.12
Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol (2001) 1.12
High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. Osteoarthritis Cartilage (2001) 1.11
Evidence for the involvement of IgE-basophil system in acute serum sickness. Clin Exp Immunol (1976) 1.10
A sonographic enthesitic index of lower limbs is a valuable tool in the assessment of ankylosing spondylitis. Ann Rheum Dis (2006) 1.09
Delayed unions and nonunions of open tibial fractures. Correlation with arteriography results. Clin Orthop Relat Res (1994) 1.09
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoarthritis Cartilage (2005) 1.08
Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int (1997) 1.08
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int (2000) 1.08
Vasoactive hormones and renal sclerosis. Kidney Int (1996) 1.07
Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients. J Clin Virol (2005) 1.07
Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension (1996) 1.07
Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation (1993) 1.06
Coronary artery perforations in the contemporary interventional era. J Interv Cardiol (2009) 1.06
Thromboxane release during percutaneous transluminal coronary angioplasty. Am Heart J (1986) 1.06
Dilated cardiomyopathies of the adult (second of two parts). N Engl J Med (1982) 1.05
Multilocus genotyping of Cryptosporidium isolates from human HIV-infected and animal hosts. J Eukaryot Microbiol (2001) 1.04
In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry. Kidney Int (1999) 1.04